Changes in progesterone and gonadoliberin levels after introduction of exogenous kisspeptin in Danio rerio females

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: According to modern concepts, the kisspeptin signaling system is the upper (central) link in the regulation of reproductive function. The neuropeptide kisspeptin is considered an indicator of a number of obstetric pathologies in humans. Therefore, it should be considered important to search for new synthetic analogues of natural kisspeptins as pharmacological agents of reproduction regulation. On the other hand, it should also be considered important to search for new effective model organisms in which certain effects manifest themselves most prominently compared to traditional experimental animals.

AIM: To quantify the effect of kisspeptin-14 on the level of gonadoliberin and progesterone in two doses, at the time typical for the action of neuropeptides, on the model organism Danio rerio.

METHODS: In this study, an analogue of kisspeptin, conventionally designated kisspeptin-14, was used. All Danio rerio females had reached puberty by the time of the experiment (6–8 months). Kisspeptin was administered in doses of 1 and 4 ng. The groups were analyzed 1 and 4 hours after administration. Before administration of the preparations, the fish were subjected to lidocaine anesthesia at a concentration of 40 mg/l for 5–6 minutes, then the drug was administered intracerebroventrically. After waiting for 1 or 4 hours, the material was collected (gonads and midbrain). Gonad and midbrain samples were homogenized, homogenates were suspended, and enzyme immunoassay was performed to determine hormone concentrations.

RESULTS: Administration of kisspeptin-14 at a dose of 1 ng led to an increase in gonadoliberin levels 4 hours after administration. With a shorter time after administration, no statistically significant results were found. Administration of kisspeptin-14 at doses of 1 and 4 ng led to an increase in progesterone levels in the gonads of Danio rerio females 1 and 4 hours after administration. At the same time, statistically significant differences compared with the control group were noted at different sample collection dates.

CONCLUSION: Intracerebroventricular administration of the kisspeptin-14 at a dose of 1 ng after 4 hours causes an increase in gonadoliberin in the structures of the midbrain. Intracerebroventricular administration of kisspeptin-14 causes an increase in progesterone in the gonads of Danio rerio females. There was no unambiguous relationship between changes in the concentration of gonadoliberin in the structures of the midbrain and changes in the concentration of progesterone in the gonads of females.

Full Text

Restricted Access

About the authors

Alexandra A. Blazhenko

Ott Research Institute of Obstetrics, Gynecology and Reproductology; Institute of Experimental Medicine

Email: alexandrablazhenko@gmail.com
ORCID iD: 0000-0002-8079-0991
SPIN-code: 8762-3604

Researcher; Junior Researcher at the Anichkov Department of Neuropharmacology

Russian Federation, Saint Petersburg; Saint Petersburg

Marina I. Kostina

Ott Research Institute of Obstetrics, Gynecology and Reproductology; Peter the Great Saint Petersburg Polytechnic University

Author for correspondence.
Email: koctena@list.ru
ORCID iD: 0009-0005-1060-5489

Student; Junior Researcher

Russian Federation, Saint Petersburg; Saint Petersburg

Alina A. Nuzhnova

Ott Research Institute of Obstetrics, Gynecology and Reproductology; Peter the Great Saint Petersburg Polytechnic University

Email: lin.panaiotis@yandex.ru
ORCID iD: 0009-0002-1607-1471

Student; Junior Researcher

Russian Federation, Saint Petersburg; Saint Petersburg

References

  1. Patent of the Russian Federation for invention № 2766689 / 15.03.2022. Bull. N 8. Blazhenko AA, Khokhlov PP, Lebedev AA, Shabanov PD. The use of lidocaine for anesthesia of a Danio rerio model organism under experimental conditions. (In Russ.)
  2. Pinilla L, Aguilar E, Dieguez C, et al. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;3(92):1235–1316. doi: 10.1152/physrev.00037.2010
  3. Chernukha GE, Tabeeva GI, Gusev DV, Shmakov RG. Kisspeptin and the reproductive system. Doctor.ru. 2017;132(3):73–78. EDN: YPQGIF (In Russ.)
  4. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011;8(96):1228–1236. doi: 10.1210/jc.2011-0089
  5. Wang B, Mechaly AS, Somoza GM. Overview and new insights into the diversity, evolution, role, and regulation of kisspeptins and their receptors in teleost fish. Front Endocrinol. 2022;13:862614. doi: 10.3389/fendo.2022.862614
  6. Ogawa S, Parhar IS. Biological significance of kisspeptin – Kiss 1 receptor signaling in the habenula of teleost species. Front Endocrinol (Lausanne). 2018;9:222. doi: 10.3389/fendo.2018.00222
  7. Kitahashi T, Ogawa S, Parhar IS. Cloning and expression of kiss2 in the zebrafish and medaka. Endocrinology. 2009;150(2):821–831. doi: 10.1210/en.2008-0940
  8. Ogawa S, Ng KW, Ramadasan PN, et al. Habenular Kiss1 neurons modulate the serotonergic system in the brain of zebrafish. Endocrinology. 2012;153(5):2398–2407. doi: 10.1210/en.2012-1062
  9. Onuma TA, Duan C. Duplicated Kiss1 receptor genes in zebrafish: distinct gene expression patterns, different ligand selectivity, and a novel nuclear isoform with transactivating activity. FASEB J. 2012;26(7):2941–2950. doi: 10.1096/fj.11-201095
  10. Zhao Y, Lin MC, Mock A, et al. Kisspeptins modulate the biology of multiple populations of gonadotropin-releasing hormone neurons during embryogenesis and adulthood in zebrafish (Danio rerio). PLoS One. 2014;9(8):e104330. doi: 10.1371/journal.pone.0104330
  11. Matsui H, Takatsu Y, Kumano S, et al. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun. 2004;320(2):383–388. doi: 10.1016/j.bbrc.2004.05.185
  12. Gottsch ML, Cunningham MJ, Smith JT, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology. 2004;145(9):4073–4077. doi: 10.1210/en.2004-0431
  13. Shahab M, Mastronardi C, Seminara SB, et al. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci USA. 2005;102(6):2129–2134. doi: 10.1073/pnas.0409822102
  14. Messager S, Chatzidaki EE, Ma D, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci USA. 2005;102(5):1761–1766. doi: 10.1016/j.bbrc.2004.05.185
  15. Sitticharoon C, Sririwichitchai R, Keadkraichaiwat I, et al. ODP417 Kisspeptin directly stimulates estrogen and progesterone secretion from human granulosa cells. J Endocr Soc. 2022;6:663–664. doi: 10.1210/jendso/bvac150.1373
  16. Guo L, Xu H, Li Y, et al. Kisspeptin-10 promotes progesterone synthesis in bovine ovarian granulosa cells via downregulation of microRNA-1246. Genes. 2022;13(2):298–310. doi: 10.3390/genes13020298
  17. Xiao Y, Ni Y, Huang Y, et al. Effects of kisspeptin-10 on progesterone secretion in cultured chicken ovarian granulosa cells from preovulatory (F1–F3) follicles. Peptides. 2011;32(10):2091–2097. doi: 10.1016/j.peptides.2011.09.001
  18. Khokhlov PP, Blazhenko AA, Komlev AS, et al. Synthetic analogues of kisspeptin peptides have pharmacological properties of natural peptides. Experimental and clinical pharmacology. 2023;86(11S):153–154. EDN: MOWCYR doi: 10.30906/ekf-2023-86s-153a
  19. Ogawa S, Nathan FM, Parhar IS. Habenular kisspeptin modulates fear in the zebrafish. Proc Natl Acad Sci USA. 2014;111(10):3841–3846. doi: 10.1073/pnas.1314184111
  20. Karaman GE, Emekli-Alturfan E, Akyüz S. Zebrafish; an emerging model organism for studying toxicity and biocompatibility of dental materials. Cell Mol Biol (Noisy-le-Grand). 2020;66(8):41–46.
  21. Kachanov DA, Lakeenkov NM, Levitin KE, et al. Danio rerio (Zebrafish) – an universal model object in preclinical research. Forcipe. 2018;1(1):49–54. EDN: ZZAPGP
  22. Clelland E, Peng C. Endocrine/paracrine control of zebrafish ovarian development. Mol Cell Endocrinol. 2009;312(1–2):42–52. doi: 10.1016/j.mce.2009.04.009
  23. Yesudhason BV, Selvan Christyraj JRS, Ganesan M, et al. Developmental stages of zebrafish (Danio rerio) embryos and toxicological studies using foldscope microscope. Cell Biol Intern. 2020;44(10):1968–1980. doi: 10.1002/cbin.11412
  24. Kettleborough RN, Busch-Nentwich EM, Harvey SA, et al. A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature. 2013;496(7446):494–497. doi: 10.1038/nature11992
  25. Varga M, Ralbovszki D, Balogh E, et al. Zebrafish models of rare hereditary pediatric diseases. Diseases. 2018;6(2):43. doi: 10.3390/diseases6020043
  26. Liu C, Li R, Li Y, et al. Spatiotemporal mapping of gene expression landscapes and developmental trajectories during zebrafish embryogenesis. Dev Cell. 2022;57(10):1284–1298.e5. doi: 10.1016/j.devcel.2022.04.009
  27. Aanes H, Collas P, Aleström P. Transcriptome dynamics and diversity in the early zebrafish embryo. Brief Funct Genomics. 2014;13(2):95–105. doi: 10.1093/bfgp/elt049
  28. Rauwerda H, Pagano JF, de Leeuw WC, et al. Transcriptome dynamics in early zebrafish embryogenesis determined by high-resolution time course analysis of 180 successive, individual zebrafish embryos. BMC Genomics. 2017;18(1):287. doi: 10.1186/s12864-017-3672-z
  29. Williams TD, Mirbahai L, Chipman JK. The toxicological application of transcriptomics and epigenomics in zebrafish and other teleosts. Brief Funct Genomics. 2014;13(2):157–171. doi: 10.1093/bfgp/elt053
  30. Hill AJ, Teraoka H, Heideman W, et al. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci. 2005;86(1):6–19. doi: 10.1093/toxsci/kfi110
  31. Parhar IS, Ogawa S, Sakuma Y. Laser-captured single digoxigenin-labeled neurons of gonadotropin-releasing hormone types reveal a novel G protein-coupled receptor (Gpr54) during maturation in cichlid fish. Endocrinology. 2004;145(8):3613–3618. doi: 10.1210/en.2004-0395
  32. Ohga H, Adachi H, Kitano H, et al. Kiss1 hexadecapeptide directly regulates gonadotropin-releasing hormone 1 in the scombroid fish, chub mackerel. Biol Reprod. 2017;96(2):376–388. doi: 10.1095/biolreprod.116.142083
  33. Li S, Zhang Y, Liu Y, et al. Structural and functional multiplicity of the kisspeptin/GPR54 system in goldfish (Carassius auratus). J Endocrinol. 2009;201(3):407–418. doi: 10.1677/JOE-09-0016
  34. Selvaraj S, Ohga H, Kitano H, et al. Peripheral administration of kiss1 pentadecapeptide induces gonadal development in sexually immature adult scombroid fish. Zool Sci. 2013;30(6):446–454. doi: 10.2108/zsj.30.446
  35. Ohga H, Selvaraj S, Adachi H, et al. Functional analysis of kisspeptin peptides in adult immature chub mackerel (Scomber japonicus) using an intracerebroventricular administration method. Neurosci Lett. 2014;561:204–207. doi: 10.1016/j.neulet.2013.12.072
  36. Kanunnikova NP. Neuroprotective properties of neuropeptides. Journal of the Grodno State Medical University. 2018;15(5):492–498. EDN: YKYYJW doi: 10.25298/2221-8785-2017-15-5-492-498
  37. Taghizadeh V, Imanpoor MR, Mehdinejad N. Study the seasonal steroid hormones of common carp in Caspian Sea, Iran. Springerplus. 2013;2(1):193. doi: 10.1186/2193-1801-2-193

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Progesterone concentration in the gonads of Danio rerio in pg/mcg of total protein after administration of kisspeptin-14: 1, control group 1 hour; 2, control group 4 hours; 3, 1 hour after administration of kisspeptin-14 at a dose of 1 ng; 4, 1 hour after administration of kisspeptin-14 at a dose of 4 ng; 5, 4 hours after administration of kisspeptin-14 with a dose of 1 ng; 6, 4 hours after administration of kisspeptin-14 with a dose of 4 ng; 7, combined control group; 8, combined group with a dose of 1 ng; 9, combined group with a dose of 4 ng; 10, combined experimental the group with a time of 1 hour; 11, is a combined experimental group with a time of 4 hours. The graph shows all the individual values and the average of these data. * p < 0,05; ** p < 0,01; *** p < 0,001; **** p < 0,0001.

Download (103KB)
3. Fig. 2. The concentration of gonadoliberin in the middle brain of Danio rerio in pg/mcg of total protein after administration of kisspeptin-14: 1, control group 1 hour; 2, control group, 4 hours; 3, 1 hour after administration of the drug with a dose of 1 ng; 4, 1 hour after administration of kisspeptin-14 with a dose of 4 ng; 5, 4 hours after administration of kisspeptin-14 with a dose of 1 ng; 6, 4 hours after administration of kisspeptin-14 with a dose of 4 ng; 7, combined control group; 8, combined group with a dose of 1 ng; 9, combined group with a dose of 4 ng; 10, combined group with time 1 hour; 11, a combined group with a time of 4 hours. The graph shows all the individual values and the average ± standard deviation according to these data. ** p < 0,01.

Download (99KB)

Copyright (c) 2025 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.